References
- Bakker-Woudenberg I. A., Lokerse A. F., Tenkate M. T., Melissen P. M., Vanvianen W. Liposomes as carriers of antimicrobial agents or immunomodulatory agents in the treatment of infections. Eur. J. Clin. Microbiol. Infect. Dis. 1993; 12: S61–S67, Suppl. 1
- Bangham A. D., Hill M. W., Miller N. G. Preparation and use of liposomes as models of biological membranes. Methods Membr. Biol. 1974; 1: 1–68
- Chowdhury M. K. R., Goswami R., Chakrabarti P. Liposometrapped penicillins in growth inhibition of some penicillin-resistant bacteria. J. Appl. Bacteriol. 1981; 51: 223–227
- Coune A. Liposomes as drug delivery system in the treatment of infectious diseases. Infection 1988; 16: 141–147
- Fattal E., Rojas J., Roblot-Treupel L., Andremont A., Couvreur P. mpicillin-loaded liposomes and nanoparticles: Comparison of drug loading, drug release and in vitro antimicrobial activity. J. Microencapsul. 1991a; 8: 29–36
- Gregoriadis G. The liposome drug-carrier concept: Its development and future. Liposomes in Biological Systems, G. Gregoriadis, A. C. Allison. Wiley, New York 1980; 25–86
- Karlowsky J. A., Zhanel G. G. Concepts on the use of liposomal antimicrobial agents: Applications for aminoglycosides. Clin. Infect. Dis. 1992; 15: 654–667
- Lagace J., Dubreuil M., Montplaisir S. Liposome-encapsulated antibiotics: Preparation, drug release and antimicrobial activity against. Pseudomonas aeruginosa. J. Microencapsul. 1991; 8: 53–61
- Lee E. H., Collatz E., Trias J., Gutmann L. Diffusion of beta-lactam antibiotics into proteoliposomes reconstituted with outer membranes of isogenic imipenem-susceptible and resistant strains of Enterobacter cloacae. J. Gen. Microbiol. 1992; 138: 2347–2351
- Lopez-Berestein G. Liposomes as carriers of antimicrobial agents. Antimicrob. Agents Chemother. 1987; 31: 675–678
- Machy P., Leserman L. Liposomes in Cell Biology and Pharmacology. John Libbey, London 1987
- Nacucchio M. C., Bellora M. J., Sordelli D. O., D'aquino M. Enhanced liposome-mediated activity of piperacillin against staphylococci. Antimicrob. Agents Chemother. 1985; 27: 137–139
- Nacucchio M. C., Bellora M. J., Sordelli D. O., D'aquino M. Enhanced liposome-mediated anti-bacterial activity of piperacillin and gentamicin against gram-negative bacilli in vitro. J. Microencapsul. 1988; 4: 303–309
- Nacucchio M. C., DiRocco P. H., Sordelli D. O. Liposomes as carriers for antibiotics. Targeted Diagn. Ther. 1990; 3: 337–354
- Ostro M. J., Cullis P. R. Use of liposomes as injectable drug delivery systems. Am. J. Hosp. Pharm. 1989; 46: 1576–1587
- Pelczar M. J., Reid R. D., Chan E. C. S. Microbiology. McGraw-Hill, New York 1977
- Praet M., Defrise Q. F., Ruysschaert J. M. Comparison of Adriamycin and derivatives uptake into large unilamellar lipid vesicles in response to a membrane potential. Biochim. Biophys. Acta. 1993; 1148: 342–350
- Royd R. F., Marr J. J. Medical Microbiology. Little, Brown, Boston 1980
- Sammour O. A. Entrapment and release of cyanocobalamin from multilamellar and reverse-phase evaporation liposomes. Egypt. J. Appl. Sci. 1992; 7: 130–141
- Shaw I. H., Knight C. G., Dingle J. T. Liposomal retention of a modified anti-inflammatory steroid. Biochem. J. 1976; 158: 473–476
- Swenson C. E., Popescu M. C., Ginsberg R. S. Preparation and use of liposomes in the treatment of microbial infections. CRC Crit. Rev. Microbiol. 1988; 15: 1–31, Suppl. 1
- Szoka F., Papahadjopoulos D. Procedure for reparation of liposomes with large internal aqueous space and high capture by reversephase evaporation. Proc. Natl. Acad. Sci. USA 1978; 75: 4194–4198
- Woudenberg I. A. J., Lokerse A. Liposomes and lipid carriers in the treatment of microbial infections. Scand. J. Infect. Dis. Suppl. 1991; 74: 34–41